Refactor Capital is a Burlingame, CA-based $50M early-stage venture capital firm that invests in areas such as applied biology, healthcare, crypto, food, wellness, transportation, aerospace, and more. The firm primarily invests in seed-stage companies.
As of March 2017, Refactor has invested in 20 software companies, half of them supporting healthcare and life sciences. Other areas represented in its portfolio are agriculture, financial, and legal services. The average check size is about $500,000, with the fund expecting to have around 40 to 50 companies in their portfolio.
As of January 2019, Refactor has 28 companies in its portfolio.
A satellite communications company building small telecommunication satellites.
A synthetic biology company offering a bioreactor facility for fermentation on demand services.
A company replacing petroleum-based chemicals with plant-derived alternatives
A company offering a smart medication management device that is headquartered in New York City, New York and was founded in 2012 by Kal Vepuri and Kut Akdogan.
A biotechnology company developing edible food coatings
Associated investment funds
David Lee is back with a new fund: Refactor Capital
Refactor Capital cofounder highlights seed stage fund strategy - MedCity News
Documentaries, videos and podcasts
Cambridge Cancer Genomics
- SV AngelSV Angel is an early stage venture capital fund. SV Angel has invested in companies such as Google, PayPal, Facebook, Twitter, Dropbox, Pinterest, Snap, Airbnb, Slack, Square, Docker, Buzzfeed, Stripe, Twilio, GitHub, Warby Parker, Gusto, Optimizely and Hugging Face.
- Andreessen Horowitz (a16z)Andreessen Horowitz (also named a16z) is a US venture capital firm, founded by Marc Andresseen and Ben Horowitz in 2009.